Gastrointestinal cancer metastasis and lymphatic advancement

Surgery Today

Volumn 40, Issue 4, 2010, Pages 301-306

  Kumagai, Kazuhide ^a   Shimizu, Kouji ^a   Yokoyama, Noboru ^a   Aida, Sadatsugu ^a   Tanaka, Takayuki ^a   Yamagata, Kennichi ^a  

^a SHOWA UNIVERSITY   (Japan)

Author keywords

Extranodal invasion; Lymph reflux; Lymphaticovenous communication; Lymphogenous metastasis

Indexed keywords

CANCER INVASION; DIGESTIVE SYSTEM CANCER; HUMAN; LIVER METASTASIS; LYMPH FLOW; LYMPH NODE METASTASIS; LYMPHANGIOGENESIS; LYMPHATIC SYSTEM EXAMINATION; LYMPHOVENOUS ANASTOMOSIS; NONHUMAN; PERITONEUM METASTASIS; REVIEW; TUMOR VASCULARIZATION; ANIMAL; GASTROINTESTINAL TUMOR; METASTASIS; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY; RAT; VEIN;

ANIMALS; GASTROINTESTINAL NEOPLASMS; HUMANS; LYMPHATIC METASTASIS; NEOPLASM METASTASIS; RATS; VEINS;

EID: 77953919962     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4142-2     Document Type: Review

References (54)

1. Fidler IJ. Molecular biology of cancer invasion and metastasis. In: DeVita V Jr, Hellman S, Rosenburg SA, editors. Cancer principles and practice of oncology. Philadelphia: Lippincott-Raven; 2001. p. 135-53.
2. Ruoslahti E. How cancer spread. Sci Am 1996;275:72-7.
3. Folkman J, Klagsburn M. Angiogenetic factors. Science 1987; 235:442-7.
4. Goldman E. The growth of malignant disease in man and the lower animals with special reference to the vascular system. Lancet 1907;2:1236-40.
5. Greenblatt M, Shubik P. Tumor angiogenesis: transfi lter diffusion studies in the hamster by transparent chamber technique. J Natl Cancer Inst 1968;41:111-24.
6. Sleeman JP, Krishnan J, Kirkin V, Baumann P. Markers for the lymphatic endothelium: In search of the holy grail? Microsc Res Tech 2001;55:61-9.
7. Swartz MA, Skobe M. Lymphatic function, lymphangiogenesis, and cancer metastasis. 2001, Microsc Res Tech 2001;55:92-9.
8. Burn JL. Obstructive lymphopathy. Ann R Coll Surg Engl 1968; 42:93-113.
9. Paget S. The distribution of secondary growths in cancer of the breast. Lancet 1889;1:571-3.
10. MacDonald IC, Groom AC, Chambers AF. Cancer spread and micrometastasis development: Quantitative approaches for in vivo models. BioEssays 2002;24:885-93.
11. Hagiwara A, Takahashi T, Sawai K, Taniguchi H, Shimotsuma M, Okano S, et al. Milky spots as the implantation site for malignant cells in peritoneal dissemination in mice. Cancer Res 1993; 53:687-92.
12. Shimotsuma M, Shields JW, Simpson-Morgan MW, Sakuyama A, Shirasu M, Hagiwara A, et al. Morpho-physiological function and role of omental milky spots as omentum associated lymphoid tissue (OALT) in the peritoneal cavity. Lymphology 1993;26: 90-101.
13. Kiyasu Y, Kaneshima S, Koga S. Morphogenesis of peritoneal metastasis in human gastric cancer. Cancer Res 1981;41:1236-9.
14. Koga S, Kudo H, Kiyasu Y, Kaneshima S, Iitsuka Y, Takeuchi T, et al. A scanning electron microscopic study on the peritoneal implantation of ascites hepatoma AH100B cells in rats. Gann 1980;71:8-13.
15. Yonemura Y. Mechanism of the formation of peritoneal dissemination. In: Yonemura Y, editor. Peritoneal dissemination. Kanazawa Maeda Shoten; 1998. p. 1-44.
16. Fidler IJ. Selection of successive tumor line for metastasis. Nat New Biol 1973;242:148-9.
17. Liotte LA. Tumor invasion and metastasis-Role of the extracellular matrix. Cancer Res 1986;46:1-7.
18. Weidner N, Semple JP, Welch WR, Folkman J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N Engl J Med 1991;324:1-8.
19. Clarijs R, Ruiter DJ, de Waal RM. Lymphangiogenesis in malignant tumors: does it occur?. J Pathol 2001;193:143-6.
20. Karpanen T, Alitalo K. Lymphatic vessels as targets of tumor therapy. J Exp Med 2001;194:37-42.
21. Leak LV. Electron microscopic observations on lymphatic capillaries and the structural components of the connective tissuelymph interface. Microvasc Res 1970;2:361-91.
22. Casley-Smith JR, Florey HW. The structure of normal small lymphatics. Q J Exp Physiol 1961;46:101-6.
23. Witte MH, Bernas MJ, Martin CP, Witte CL. Lymphangiogenesis and lymphangiodysplasia: from molecular to clinical lymphology. Microsc Res Tech 2001;55:122-45.
24. Leak LV, Burke JF. Fine structure of the lymphatic capillary and the adjoining connective tissue area. Am J Anat 1966;118: 785-809.
25. Yokote T, Ishiyama S, Saito T, Teshima S, Narushima Y, Muratas K, et al. Lymph node metastasis as a signifi cant prognostic factor in gastric cancer: a multiple logistic regression analysis. Scand J Gastroenterol 2004;39:380-4.
26. Muratore A, Zimmitti G, Lo Tesoriere R, Mellano A, Massucco P, Capussotti L. Low rates of loco-regional recurrence following extended lymph node dissection for gastric cancer. Eur J Surg Oncol 2009;35:588-612.
27. Jeltsch M, Kaipainen A, Joukov V, Meng X, Lakso M, Rauvala H, et al. Hyperplasia of lymphatic vessels in VEGF-C transgenic mice. Science 1997;276:1423-5.
28. Skobe M, Hawighorst T, Jackson DG, Prevo R, Janes L, Valasco P, et al. Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis. Nat Med 2001;7: 192-8.
29. Stacker SA, Caesar C, Baldwin ME, Thornton GE, Williams RA, Prevo R, et al. VEGF-D promotes the metastatic spread of tumor cells via the lymphatics. Nat Med 2001;7:186-91.
30. Skobe M, Detmar M. Structure, function, and molecular control of the skin lymphatic system. J Invest Dermatol 2000;5:14-9.
31. Kaipainen A, Korhonen J, Mustonen T, van Hinsbergh VW, Fang GH, Dumont D, et al. Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc Natl Acad Sci USA 1995;92:3566-70.
32. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, et al. VEGF-C receptor binding and patter of expression with VEGFR-3 suggested a role in lymphatic vascular development. Development 1996;122:3829-37.
33. Achen MG, Jeltsch M, Kukk E, Makinen T, Vitali A, Wilks AF, et al. Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinase VEGF receptor 2 (Flk-1) and VEGF receptor 3 (Flt-4). Proc Natl Acad Sci USA 1998;95:548-53.
34. Lymboussaki A, Achen MG, Stacker SA, Alitalo K. Growth factors regulation lymphatic vessels. Curr Top Microbiol Immunol 2000;251:75-82.
35. Valtola R, Salven P, Heikkila P, Taipale J, Joensuu H, Rehn M, et al. VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Am J Pathol 1999;154:1381-90.
36. Birck A, Kirkin AF, Zeuthen J, Hou-Jensen K. Expression of basic fi broblast growth factor and vascular endothelial growth factor in primary and metastatic melanoma from the same patients. Melanoma Res 1999;9:375-81.
37. Royston D, Jackson DG. Mechanisms of lymphatic metastasis in human colorectal adenocarcinoma. J Pathol 2009;217:608-19.
38. Issa A, Le TX, Shoushtari AN, Shields JD, Swartz MA. Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype. Cancer Res 2009;69:349-57.
39. Garmy-Susini B, Varner JA. Roles of integrins in tumor angiogenesis and lymphangiogenesis. Lymphat Res Biol 2008;6: 155-63.
40. Kinmonth JB. Lymphangiography in clinical surgery and particularly in the treatment of lymphoedema. Ann R Coll Surg Engl 1954 15:300-10.
41. Mahaffy RG. Surgical aspects of lymphography. J R Coll Surg Edinb 1965;10:125-46.
42. Kinmonth JB, Taylor GW, Tracy GD, Marsh JD. Primary lymphoedema; and lymphangiographic studies of a series of 107 patients in which the lower limbs were affected. Br J Surg 1957;45:1-9.
43. Wallace S, Jackson L, Greening RR. Clinical applications of lymphangiography. Am J Roentgenol Radium Ther Nucl Med 1962;88:97-109.
44. Pressman JJ, Simon MB. Experimental evidence of direct communications between lymph nodes and vein. Surg Gynecol Obstet 1961;113:537-41.
45. Bron KM, Baum S, Abrams HL. Oil embolism in lymphangiology. Incidence, manifestations, and mechanism. Radiology 1963; 80:194-202.
46. Perez-Tamayo R, Thornbury JR, Atkinson RJ. "Second-look" lymphography. Am J Roentgenol Radium Ther Nucl Med 1963; 90:1078-86.
47. Yamagata Y, Kumagai K, Shimizu K, Masuo K, Nishida Y, Yasui A. The possibility of lymphaticovenous communication induced by the mesenteric lymph vessels obstruction (in Japanese). Nippon Shokaki Geka Gakkai Zasshi 1994;27:2500.
48. Yamagata K, Kumagai K, Shimizu K, Masuo K, Nishida Y, Yasui A. Gastrointestinal cancer metastasis and lymphogenous spread: Viewpoint of animal models of lymphatic obstruction. Jpn J Clin Oncol 1998;28:104-6.
49. Yamagata K, Kumagai K. Experimental study of lymphogenous peritoneal cancer dissemination: Migration of fluorescent-labelled tumor cells in a rat model of mesenteric lymph vessel obstruction. J Exp Clin Cancer Res 2000;19:211-7.
50. Tanaka T, Kumagai K, Shimizu K, Masuo K, Yamagata K. Peritoneal metastasis in gastric cancer with particular reference to lymphatic advancement; Extranodal invasion is a signifi cant risk factor for peritoneal metastasis. J Surg Oncol 2000;75:165-71.
51. Kumagai K, Tanaka T, Yamagata K, Yokoyama N, Shimizu K. Liver metastasis in gastric cancer with particular reference to lymphatic advancement. Gastric Cancer 2001;4:150-5.
52. Horn LC, Hentschel B, Galle D, Bilek K. Extracapsular extension of pelvic lymph node metastasis is of prognostic value in carcinoma of the cervix uteri. Gynecol Oncol 2008;108:63-7.
53. Gorgulu S, Can MF, Yagci G, Sahin M, Tufan T. Extracapsular extension is associated with increased ratio of metastatic to examined lymph nodes in axillary node-positive breast cancer. Clin Breast Cancer 2007;7:796-800.
54. Okamoto T, Tsuburaya A, Kameda Y, Yoshikawa T, Cho H, Tsuchida K, et al. Prognostic value of extracapsular invasion and fi brotic focus in single lymph node metastasis of gastric cancer. Gastric Cancer 2008;11:160-7.